不完全横筋筋炎を模倣した局所性テタヌス.

Clean hydrogen from water: emerging technologies for a sustainable energy future.

RSC advances·2026

Stable dry reforming of methane over Ni-Pt bimetallic catalysts supported on KIT-5 in a continuous flow system.

RSC advances·2026

Emerging ozone generation strategies: mechanistic insights and application-driven developments.

RSC advances·2026

Effect of Si/Zr ratio on the catalytic behavior of Pt-Cu/Zr-SBA-15 in continuous methane dry reforming.

RSC advances·2026

Origin of eukaryotic plasmalogen biosynthesis by horizontal gene transfer from myxobacteria.

Proceedings of the National Academy of Sciences of the United States of America·2026

PexR is a noncanonical regulator of the peroxide stress response in bacteria.

Nucleic acids research·2025

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Microbiota-gut-brain axis imbalance: a promising therapeutic target for preserving brain health in high-altitude environment.

Frontiers in neuroscience·2026

A dual-prototype morphological topology evolution network for clinically oriented brain tumor MRI segmentation.

Frontiers in oncology·2026

Nose-to-brain delivery of candesartan-loaded nanoemulsion: brain biodistribution and neurobehavioral outcomes in controlled cortical impact-induced traumatic brain injury.

Inflammopharmacology·2026

Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.

International journal of pharmaceutics·2026

Design and in silico validation of donor DNA for RNA-guided recombinase-mediated knockout of mstnb gene in Labeo rohita.

PloS one·2026

Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study.

Cephalalgia : an international journal of headache·2026

関連する実験動画

不完全横筋筋炎を模倣した局所性テタヌス.

関連する概念動画

Clean hydrogen from water: emerging technologies for a sustainable energy future.

Stable dry reforming of methane over Ni-Pt bimetallic catalysts supported on KIT-5 in a continuous flow system.

Emerging ozone generation strategies: mechanistic insights and application-driven developments.

Effect of Si/Zr ratio on the catalytic behavior of Pt-Cu/Zr-SBA-15 in continuous methane dry reforming.

Origin of eukaryotic plasmalogen biosynthesis by horizontal gene transfer from myxobacteria.

PexR is a noncanonical regulator of the peroxide stress response in bacteria.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Microbiota-gut-brain axis imbalance: a promising therapeutic target for preserving brain health in high-altitude environment.

A dual-prototype morphological topology evolution network for clinically oriented brain tumor MRI segmentation.

Nose-to-brain delivery of candesartan-loaded nanoemulsion: brain biodistribution and neurobehavioral outcomes in controlled cortical impact-induced traumatic brain injury.

Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.

Design and in silico validation of donor DNA for RNA-guided recombinase-mediated knockout of mstnb gene in Labeo rohita.

Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study.

関連する実験動画

不完全横筋筋炎を模倣した局所性テタヌス.

関連する概念動画

関連記事